Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients throughout the US.

Medicina supplied devices bearing false CE markings to healthcare providers including National Health Service (NHS) Trusts across the UK.

Artivion has received the PMA clearance from the US FDA for AMDS Hybrid Prosthesis device, permitting its use in treating acute DeBakey Type I aortic dissections with clinical or radiographic ...

Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have experienced a stroke.

Hyperfine has commercially launched its next-generation Swoop portable MRI system (Model 2) in select European markets.

The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.

OrthAlign has completed the first clinical procedures using its Lantern ASC system, designed for the ASC setting.

Funds will support Materna’s completion of a pivotal trial evaluating its system for reducing pelvic floor muscle injury during childbirth, as well as other commercial activities.

Experts at HLTH Europe 2026 agreed that healthcare innovations won't meet their full potential until healthcare services can implement them.

Roche has introduced its Axelios 1 platform, a next-generation sequencing system that is available for research use and powered by its SBX technology.

Experts at HLTH Europe 2026 note that patient adherence-focused health technologies should be flexible, engaging, adaptable and affordable.

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.